Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

SPECIALLÆGEPRAKSISSELSKABET TRIANGLEN FOR GYNÆKOLOGI OG OBSTETRIK ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Bankruptcy risk for industry   0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7% 0.7%   Bankruptcy risk   4.2% 2.7% 1.7% 2.3% 1.2% 1.0% 11.2% 11.2%   Credit score (0-100)   50 62 73 63 81 84 22 22   Credit rating   BBB BBB A BBB A A BB BB   Credit limit (kDKK)   0.0 0.0 4.2 0.0 71.8 196.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   4,947 5,983 7,464 6,507 6,919 8,076 0.0 0.0   EBITDA   417 299 1,481 426 1,097 1,060 0.0 0.0   EBIT   15.9 48.8 1,162 163 959 921 0.0 0.0   Pre-tax profit (PTP)   15.8 46.5 1,150.7 165.5 958.2 912.3 0.0 0.0   Net earnings   7.9 34.2 896.4 127.5 745.4 711.6 0.0 0.0   Pre-tax profit without non-rec. items   15.8 46.5 1,151 165 958 912 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 648 509 371 233 0.0 0.0   Shareholders equity total   87.9 122 1,018 256 876 1,088 1,008 1,008   Interest-bearing liabilities   0.0 100 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,530 3,140 4,388 1,965 2,413 2,665 1,008 1,008   Net Debt   -775 -1,682 -2,967 -622 -926 -1,600 -1,008 -1,008     See the entire balance sheet 1000.0 Volume  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   4,947 5,983 7,464 6,507 6,919 8,076 0.0 0.0   Gross profit growth   -29.0% 21.0% 24.8% -12.8% 6.3% 16.7% -100.0% 0.0%   Employees   8 10 10 12 10 9 0 0   Employee growth %   100.0% 25.0% 0.0% 20.0% -16.7% -10.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,530 3,140 4,388 1,965 2,413 2,665 1,008 1,008   Balance sheet change%   -37.8% 24.1% 39.8% -55.2% 22.8% 10.4% -62.2% 0.0%   Added value   416.6 298.8 1,481.4 426.4 1,222.1 1,059.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   -802 -500 79 -527 -277 -277 -233 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   3.0 4.0 5.0 5.0 5.0 5.0 0.0 0.0   1000.0 Profitability  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   0.3% 0.8% 15.6% 2.5% 13.9% 11.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   0.5% 1.7% 30.9% 5.3% 43.8% 36.4% 0.0% 0.0%   ROI %   4.1% 11.7% 132.4% 23.8% 158.2% 92.0% 0.0% 0.0%   ROE %   3.1% 32.5% 157.2% 20.0% 131.7% 72.5% 0.0% 0.0%   1000.0 Solidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Equity ratio %   3.5% 3.9% 23.2% 13.0% 36.3% 40.8% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -185.9% -562.9% -200.3% -145.9% -84.4% -150.9% 0.0% 0.0%   Gearing %   0.0% 82.3% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   0.0% 4.6% 22.8% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Liquidity  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Quick Ratio   0.8 1.1 1.2 0.9 1.6 1.8 0.0 0.0   Current Ratio   0.8 1.1 1.2 0.9 1.6 1.8 0.0 0.0   Cash and cash equivalent   774.6 1,782.7 2,966.8 622.3 926.4 1,599.6 0.0 0.0   1000.0 Capital use efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   -363.6 233.9 548.8 -132.1 765.2 1,088.9 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2019/6 2019 2020/6 2020 2021/6 2021 2022/6 2022 2023/6 2023 2024/6 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   52 30 148 36 122 118 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   52 30 148 36 110 118 0 0   EBIT / employee   2 5 116 14 96 102 0 0   Net earnings / employee   1 3 90 11 75 79 0 0